DelNova: Addressing complications from Botox (217)

Episode 17 May 24, 2022 00:19:03
DelNova: Addressing complications from Botox (217)
Innovation4Alpha
DelNova: Addressing complications from Botox (217)

May 24 2022 | 00:19:03

/

Show Notes

DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a different medical use and route of administration. The novel formulation will manage undesirable side effects resulting from neurotoxin injections in both medical and cosmetic applications. 

Other Episodes

Episode 13

May 18, 2022 00:27:35
Episode Cover

Getting Why Right: Colorado Medical Society (213)

Bryan Campbell leads the Colorado Medical Society and started of his mission going back to the fundamental question of why CMS exists. How can...

Listen

Episode 2

January 11, 2022 00:16:45
Episode Cover

David Finkel Founder/CEO of Maui Mastermind - (Part 2) (202)

Listen

Episode 27

August 16, 2022 00:33:14
Episode Cover

Star Harbor: Accelerating innovation through space education, training and research (228)

Maraia Tanner is the CEO of Star Harbor based in Lone Tree, Colorado. She shares insights into the mission of the organization and how...

Listen